9:50am ET
Health and Healthcare
RBC’s 5 Top Biotech Stocks to Buy for 2015
One sector that could be poised to do well could be the biotech arena, and the team at RBC has five top stocks for investors to focus on as best ideas.
Companies
Regeneron Pharmaceuticals Inc
$827.72
▼ $15.75 (−1.87%) today
Markets closed · 12:23am ET
REGN Coverage
Page 13
9:40am ET
Health and Healthcare
Credit Suisse Sees 2 Biotech Stocks That Could Double in 2015
Credit Suisse has released a biotech research report that has their top picks for upside potential in the biotech segment for 2015.
Chris Lange 8:40am ET
Health and Healthcare
UBS Very Positive on Top Biotech Stocks Ahead of Earnings
Rising trends in prescriptions and higher, yet beatable increases in earnings have set the table for what the UBS biotech analysts feels could be a very solid third-quarter earnings season.
8:30am ET
Health and Healthcare
Deutsche Bank’s 4 Top Biotech Stocks to Buy for This Year and 2015
A new report from the biotech team at Deutsche Bank fields questions from clients asking for specific stocks to buy for the rest of this year and 2015, and the analysts keep…
8:15am ET
Investing
Top Analyst Upgrades and Downgrades: Avago, Exelixis, Gap, Groupon, Staples, Tesla and More
These are the top analyst upgrades and downgrades from 24/7 Wall St. for Tuesday, September 2, 2014.
9:15am ET
Investing
Top Insider Selling of Stocks This Week from Biotech, Tech, Sam Zell, and More
ThinkstockIn what was yet another very volatile week for the markets, insider selling and insider buying has been active. We have evaluated some of the top insider selling transactions this last week.…
9:05am ET
Investing
Top Analyst Upgrades and Downgrades: Apple, ARM, DaVita, GE, GoPro, Itron and Many More
These are the top analyst upgrades, downgrades and initiations from Wall Street firms on Monday, July 21, 2014. They include Apple, ARM Holdings, DaVita Healthcare, General Electric, GoPro and Itron.
9:15am ET
Health and Healthcare
Analyst Issues Top Biotech Stocks to Buy Ahead of Earnings
ThinkstockFor the third time in less than two weeks, one of the top brokerage firms we cover at 24/7 Wall Street has loudly stepped up to the plate and advised investors to buy…
2:05pm ET
Health and Healthcare
Will Celgene Trigger Other Biotech Stock Splits?
Celgene has decided to join the stock split game. Even though stock splits change nothing fundamentally, 24/7 Wall St. would like to see several competing biotechs join in on the fun.
9:25am ET
Health and Healthcare
Large Cap Biotech Stocks to Buy Leading the Comeback Rally
A new research note from Credit Suisse maintains that the top large cap biotech leaders are leading the comeback rally from the hard sell-off. Here are the top large cap biotech stocks…
8:45am ET
Health and Healthcare
Top Biotech Stocks to Buy According to Portfolio Managers
A new research report from Cowen suggests that biotech investors appear to be looking forward to what they describe as a "return to normalcy" following the roller coaster ride of early 2014.
8:55am ET
Investing
Top Analyst Upgrades and Downgrades: Control4, Cree, NetApp, Twitter, Yahoo!, Yelp and More
These are the top analyst upgrades, downgrades and initiations from Wall Street on Wednesday, April 16, 2014. They include Control4, Cree, NetApp, Twitter, Yahoo! and Yelp.
8:25am ET
Health and Healthcare
Credit Suisse Says Grit Your Teeth and Buy Biotech
In a new report, the Credit Suisse team says large cap biotech is cheaper than the S&P 500 on 2016 and 2017 numbers. Here are the top biotech names rated Outperform at…
8:55am ET
Health and Healthcare
Morgan Stanley Starts Mixed Coverage on Top Biotech Stocks
courtesy of Morgan StanleyLike many of its Wall Street peers, the brutal sell-off in the biotechnology space has Morgan Stanley taking a closer look at the top names. The firm initiated coverage…
9:55am ET
Health and Healthcare
Top Biotechnology Stocks On Sale Again
For the second time in less than a month, the biotechnology sector got whacked when once again, chatter coming from the halls of Congress hit the sector hard. This may be a…